EMA Alerts Stakeholders To Next Steps For EU Drug Safety Monitoring System
Executive Summary
The European Medicines Agency has outlined key steps it plans to take over the next couple of years to improve the EudraVigilance drug safety monitoring system, including easier access for organizations and users, better communications with stakeholders, and the introduction of new reporting formats. Predictably, there's a Brexit sting in the tail.